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Turning points
Coming early to the
late genes
Ira Herskowitz
When I was an undergraduate at
Caltech, I worked in Bob Edgar’s
laboratory on an obscure aspect of
phage T4 morphogenesis, which had
previously been studied by a
little-known South African
geneticist, Sydney Brenner [1]. I
remember a journal club presented
by one of the graduate students in
the lab, about the lac repressor
binding to DNA. I don’t remember
the precise experiments but I know
I was impressed by the logic and the
stepwise manner in which they
proceeded. It was molecular biology
— exciting, elegant and revealing.
The Edgar lab worked on
bacteriophage morphogenesis, and so
I was well aware of the components
(heads, tails, tailfibers, baseplates,
whiskers, collars, and so on) that
make up the phage particle, and of
their corresponding genes, which
were called ‘late’ genes. I was
standing outside the Edgar lab one
day, next to the enormous map of the
phage T4 rII locus that adorned the
wall and something struck me that I
hadn’t appreciated before. It made
sense that the genes encoding the
phage head and tail proteins were
expressed late, but what was the
mechanism that ensured that they
were expressed late? Even more
striking, why were these genes not
expressed if DNA replication, an
early event, was blocked?
I went on to graduate school at
the Massachusetts Institute of
Technology with a continuing
interest in the control of gene
expression, thinking that I would
work in some area of developmental
biology. I didn’t intend to study
phage but I found it impossible to
give up working with an organism
where I could do lots of experiments
and ask lots of questions, and so I
joined Ethan Signer’s lab to work on
bacteriophage λ.
During my first year, at a lab
journal club, I heard about a paper by
Dambly, Couturier and Thomas [2]
concerning a phenomenon they
called ‘functional rescue’. They were
studying mutants of λ that were
defective in one of their late genes,
the R gene. Mutants lacking R
cannot lyse the host cell and thus do
not form plaques on bacterial lawns.
Phage λ can exist in a silent form
integrated into the host bacterial
chromosome, as a prophage. Although
a λ prophage will normally repress an
infecting λ phage, these experiments
were done using an infecting λ phage
that is insensitive to repression by the
λ prophage. The Dambly et al. paper
[2] made the striking observation that
such an insensitive phage with a
defective R gene could activate the
normally silent R gene of a prophage
and cause the cell to lyse.
How was it possible for the
infecting λ to turn on the prophage R
gene? Answering this question
involves understanding why the R
gene of the prophage is silent under
ordinary circumstances. The reason
is that transcription of R requires
expression of the Q gene, which is
not expressed by the λ prophage.
Dambly et al. showed that an
infecting phage could turn on the
prophage R gene by synthesizing Q
protein (which it was able to do
because the infecting phage was
insensitive to the prophage’s
repressor). The Q protein could then
activate transcription of the prophage
R gene and thereby provide the
missing function for the infecting
phage to grow lytically (see Figure 1).
Although λ genetics has a
reputation for being arcane and
complex (which perhaps developed
after I entered the field), this paper
made a lot of sense to me. The
experiments were straightforward,
I loved the logic and I could see how
this type of experiment illuminated
the mechanisms underlying the
control of gene expression. There
may also have been some personal
resonance with these experiments
because they involved late genes.
As I sat through this journal club,
I was compulsively doodling
‘Functional Rescue’ in highly floral,
psychedelic style (it was, after all,
1968) and thinking how wonderful it
would be to do this type of work.
Towards the end of my first year,
Ethan Signer suggested I should
check out some strains in the lab
collection that contained various
deletions of the λ prophage, in
particular, one strain with a deletion
that ended in the S gene, which is
adjacent to R. We knew the R gene
must be present but it couldn’t be
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Figure 1
Functional rescue in phage λ. A phage (blue)
with a defective R gene infects a bacterial cell
that already contains a silent λ prophage (red)
integrated into the host genome. Expression
of the R gene (green) is needed for lysis of an
infected bacterial cell but the prophage R
gene is silent and that of the infecting phage
is defective. The infecting phage activates the
silent prophage R gene by synthesizing the Q
protein (yellow). Synthesis of R protein
(green) allows lysis of the host cell and
release of intracellular phage.
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turned on by an infecting phage; for
some reason, Q wasn’t working on
this prophage.
This set in motion my studies on
functional rescue, which led to
identification of the site where Q
acts to control transcription of all the
λ late genes [3]. I suppose you could
say that my interest in gene control
might have led me in this general
direction anyway, but it was the
Dambly et al. paper that pointed me
towards Q and the late genes.
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Quick guide
PI 3-kinase
Sonja Krugmann and
Heidi Welch
What is it? PI 3-kinase is the
enzyme that phophorylates
membrane lipids at the 3′ position
of an inositol ring to generate the
essential but cumbersomely named
intracellular second messenger
phosphatidylinositol 3,4,5-triphosphate
(PtdIns(3,4,5)P3).
Also known as¼ phosphoinositide
3OH-kinase, phosphatidylinositol
3OH-kinase, or simply PI3K.
Its known functions are¼ to control
cellular features such as cell shape,
adhesion, motility, proliferation,
growth, differentiation and survival.
And if that’s not enough, it also
regulates such specialised cellular
responses as superoxide formation
and secretion.
How is it activated? PI 3-kinase is a
cytoplasmic enzyme made up of a
catalytic subunit, p110, and a
regulatory subunit, p85. In response
to the activation of cell-surface
receptors for a wide variety of
hormones, neurotransmitters and
growth factors, PI 3-kinase
translocates to the plasma
membrane by binding its regulatory
subunit to the receptor or receptor-
associated proteins. This increases
its catalytic activity and puts it in
the ideal place for producing
PtdIns(3,4,5)P3 from the membrane
lipid PtdIns(4,5)P2.
It first came to prominence¼ around
10 years ago and since then the
signalling research community has
been in PI 3-kinase frenzy. Because
of its interactions with protein
kinases and with GTPases and their
regulators, not to mention the
involvement in cell proliferation and
survival, no self-respecting
signalling conference would ignore
PI 3-kinase.
Most likely to be mentioned by¼ Lewis
Cantley, Julian Downward, Len
Stephens or Mike Waterfield.
Does it have relatives?  You bet. Every
cell in every eukaryote seems to have
a form of PI 3-kinase. They all
phosphorylate phosphoinositides but
they differ in their substrate
specificity, primary structure and
mode of regulation.
So what don’t we know about it? The
pathways downstream of PI 3-kinase
are turning out to be more complex
than was originally thought. So far,
there are only three known direct
targets for PtdIns(3,4,5)P3 in vivo —
the protein kinases PDK, PKB and
Btk — although several other
proteins are known to bind
PtdIns(3,4,5)P3 in vitro. We are only
just starting to learn about the
specific roles of different forms of
PI 3-kinase.
Does it have commercial potential?
An oncogenic form of PI 3-kinase has
recently been found, and PI 3-kinase
is indirectly involved in other cancers
via oncogenic versions of some
PI 3-kinase activators (such as
tyrosine kinases and Ras). It is also
implicated in inflammatory diseases
such as rheumatoid arthritis and
asthma, by virtue of its regulation of
superoxide radical production. Not
surprisingly, there is huge
commercial interest in finding ways
to manipulate PI 3-kinase activity.
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